Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CNY 115.35 million compared to CNY 86.34 million a year ago. Net income was CNY 1.01 million compared to net loss of CNY 10.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.00053 compared to basic loss per share from continuing operations of CNY 0.00561 a year ago. For the nine months, sales was CNY 357.14 million compared to CNY 251.61 million a year ago. Net income was CNY 1.82 million compared to net loss of CNY 15.91 million a year ago. Basic earnings per share from continuing operations was CNY 0.00096 compared to basic loss per share from continuing operations of CNY 0.00839 a year ago.